Even companies manufacturing and marketing already successful pharmacogenomic drug-test combinations continue to face difficulties.
即便是生产和推广已经成功的药物基因组学产品的产家也在不断面临着困难。
2
The progress of pharmacogenomic research in the effects of drug treatment on rheumatic diseases could prevent adverse reactions, and provide reasonable guidance to clinical treatment.